GetTopicDetailResponse(id=6f9e10399399, topicName=丹曲林, introduction=丹曲林, content=麗珠集團的注射用丹曲林鈉為國內(nèi)首仿, image=null, comments=1, allHits=878, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=10, adminEncryptionId=7a3710, adminName=lovetcm, createdBy=7a3710, createdName=lovetcm, createdAvatar=, createdTime=Thu Oct 29 10:26:09 CST 2020, time=2020-10-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=107611, tagList=[TagDto(tagId=107611, tagName=丹曲林)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=895363, encodeId=39a8895363e0, content=<a href='/topic/show?id=48201039929a' target=_blank style='color:#2F92EE;'>#麗珠集團#</a>的注射用<a href='/topic/show?id=6f9e10399399' target=_blank style='color:#2F92EE;'>#丹曲林#</a>鈉為國內(nèi)首仿, objectTitle=惡性高熱首個國內(nèi)仿制藥獲批, objectType=article, longId=202600, objectId=58aa2026004c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201028/1603897501673_5295905.jpg, objectUrl=/article/show_article.do?id=58aa2026004c, replyNumber=0, likeNumber=165, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58aa2026004c, moduleTitle=惡性高熱首個國內(nèi)仿制藥獲批, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=58aa2026004c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
lovetcm
2020-10-29
